McIntosh David M 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Jun 8, 2011
Insider Transaction Report
Form 4
McIntosh David M
Director
Transactions
- Award
Stock Options (right-to-buy)
2011-06-06+20,000→ 20,000 totalExercise: $1.25Exp: 2021-06-06→ Common Stock (20,000 underlying)
Holdings
- 20,000
Stock Options (right-to-buy)
Exercise: $1.17Exp: 2020-06-14→ Common Stock (20,000 underlying) - 2,800(indirect: By son)
Common Stock
- 125,000
Stock Options (right-to-buy)
Exercise: $0.80From: 2007-04-20Exp: 2014-04-20→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]These options vest and become exercisable in full on June 06, 2012
- [F2]These options vest and become exercisable in full on June 14, 2011.